Skip to main content

QTRX

Stock
Health Care
Medical Devices

Performance overview

QTRX Price
Price Chart

Forward-looking statistics

Beta
1.75
Risk
68.72%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

quanterix offers an ultra-sensitive diagnostic platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today. the single molecule array (simoaâ„¢) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant unmet needs in life science research, in-vitro diagnostics, companion diagnostics, blood screening, and more. quanterix is a venture capital backed company and the exclusive licensee of a broad intellectual property portfolio initially developed at tufts university by dr. david walt, scientific founder of quanterix and illumina (nasdaq: ilmn).

Company info

SectorHealth Care
IndustryMedical Devices
Employees271
Market cap$650.6M

Fundamentals

Enterprise value$27.7M
Revenue$135.7M
Revenue per employee—
Profit margin-35.28%
Debt to equity11.51

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.24
Dividend per share—
Revenue per share$3.52
Avg trading volume (30 day)$4M
Avg trading volume (10 day)$4M
Put-call ratio—

Macro factor sensitivity

Growth+1.0
Credit+3.5
Liquidity+1.0
Inflation-1.8
Commodities-0.7
Interest Rates-4.6

Valuation

Dividend yield0.00%
PEG Ratio-7.93
Price to sales2.00
P/E Ratio-7.93
Enterprise Value to Revenue0.20
Price to book0.86

Upcoming events

Next earnings dayAugust 9, 2024
Next dividend day—
Ex. dividend day—

News

Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates

Quanterix Corporation (QTRX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.26 per share a year ago.

Zacks Investment Research (May 12, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free